The global general surgical devices market size was estimated to be USD 16.38 billion in 2023 and is expected to reach at USD 43.3 billion by 2033 with a CAGR of 9.25% during the forecast period 2023-2033. Increase in prevalence of chronic diseases such as cardiac related diseases, gastrointestinal diseases & osteoporosis, surge in number of surgeries performed, rising technological development, growing adoption of advanced surgeries such as robotic & computer-assisted surgeries, growing geriatric population, increasing awareness of surgical facilities, rising adoption of portable surgical instruments, and surge in release of innovative surgical devices are the key factors supporting to the market growth.
Surge in release of innovative surgical devices is predicted to boost the market growth during the forecast period. For instance, in September 2022, The THUNDERBEATTM Open Fine Jaw Type X surgical energy devices, created for use in open surgery, were released by Olympus Corporation.
By Type, Disposable surgical supplies was the highest revenue-grossing segment in the global general surgical devices market in 2022 owing to increasing demand for disposable supplies such as syringes, needles, and catheters, growing awareness about diseases transmitted through surgical devices, and rising development of cost effective disposable products. Additionally, Open surgery instruments is predicted to grow at fastest CAGR during the forecast period owing to the increasing technological advancements and rising launch of technologically advanced products. For instance, in September 2021, Olympus Corporation unveiled the initial products in the innovative POWERSEAL™ family of advanced bipolar surgical energy devices, suitable for both laparoscopic and open surgical procedures.
By Product, Handheld devices was the highest revenue-grossing segment in the global general surgical devices market in 2022 owing to the growing development of advanced devices, increasing minimally invasive surgical procedures, rising outpatient surgeries, and surge in launch of new products by key market players. For instance, in January 2022, Smith+Nephew has declared the extension of indications on its CORI Surgical System, the leading handheld robotic solution in total knee arthroplasty, to encompass total hip arthroplasty (THA), making it the industry's most advanced and efficient option for both procedures. Additionally, Laparoscopic Devices is predicted to grow at fastest CAGR during the forecast period owing to the rising burden of non-communicable diseases & injuries, growing technological improvements, and increasing launch of innovative products.
By Application, Orthopaedic surgery was the highest revenue-grossing segment in the global general surgical devices market in 2022 owing to increasing prevalence of bone diseases, rising geriatric population growing favourable reimbursement, surge in demand for diagnosis methods & imaging technology in orthopaedic surgery, and increasing launch of new products. For instance, in November 2021, OrthAlign, Inc., has officially launched Lantern, the newest smart surgical technology designed for total and partial knee replacement surgery. Additionally, Cardiology is predicted to grow at fastest CAGR during the forecast period owing to rising lifestyle changes, growing prevalence of cardiovascular disorders, and increasing technological developments.
By End-user, Hospitals was the highest revenue-grossing segment in the global general surgical devices market in 2022 owing to increasing healthcare expenditure, surge in number of hospitals, rising technological advancements, and growing introduction of innovative products. Additionally, Ambulatory surgical centers is predicted to grow at fastest CAGR during the forecast period owing to the increasing public awareness for one-day procedures, rising usage of cutting-edge surgical equipment, growing reimbursement policies, and surge in approval for innovative products by regulatory bodies. For instance, in June 2022, Xenco Medical has broadened its portfolio of surgical devices for ambulatory surgical centers (ASCs) with the clearance and release of the Multilevel CerviKit by the United States Food and Drug Administration. This new addition builds upon Xenco Medical's pioneering single-use cervical spine technology, now offering a complete range of implants and single-use instruments suitable for anterior cervical spine procedures involving 2, 3, and 4 levels.
North America region is anticipated for the highest revenue share during the forecast period owing to the rising favourable reimbursement policies, increasing healthcare expenditures, growing demand for innovative products, and surge in launch of new products. For instance, in September 2021, Ethicon, a division of Johnson & Johnson Medical Devices Companies, introduced ECHELON ENDOPATH Staple Line Reinforcement (SLR), an innovative buttressing device aimed at enhancing staple line durability and minimizing potential complications in bariatric, thoracic, and general surgical procedures. Additionally, Asia Pacific region is predicted to grow at fastest CAGR during the forecast period owing to the increasing investment by major market players, rising government initiatives for improvements in reimbursement policies, surge in awareness about reconstructive or plastic surgeries, growing technological advancements, and increasing introduction of technologically advanced systems. For instance, in July 2022, SS Innovations, headquartered in New Delhi, unveiled SSI Mantra, India's inaugural general robotic surgery system, and the Rajiv Gandhi Cancer Institute became its first commercial installation.
Surge in release of innovative surgical devices is predicted to boost the market growth during the forecast period. For instance, in September 2022, The THUNDERBEATTM Open Fine Jaw Type X surgical energy devices, created for use in open surgery, were released by Olympus Corporation.
By Type, Disposable surgical supplies was the highest revenue-grossing segment in the global general surgical devices market in 2022 owing to increasing demand for disposable supplies such as syringes, needles, and catheters, growing awareness about diseases transmitted through surgical devices, and rising development of cost effective disposable products. Additionally, Open surgery instruments is predicted to grow at fastest CAGR during the forecast period owing to the increasing technological advancements and rising launch of technologically advanced products. For instance, in September 2021, Olympus Corporation unveiled the initial products in the innovative POWERSEAL™ family of advanced bipolar surgical energy devices, suitable for both laparoscopic and open surgical procedures.
By Product, Handheld devices was the highest revenue-grossing segment in the global general surgical devices market in 2022 owing to the growing development of advanced devices, increasing minimally invasive surgical procedures, rising outpatient surgeries, and surge in launch of new products by key market players. For instance, in January 2022, Smith+Nephew has declared the extension of indications on its CORI Surgical System, the leading handheld robotic solution in total knee arthroplasty, to encompass total hip arthroplasty (THA), making it the industry's most advanced and efficient option for both procedures. Additionally, Laparoscopic Devices is predicted to grow at fastest CAGR during the forecast period owing to the rising burden of non-communicable diseases & injuries, growing technological improvements, and increasing launch of innovative products.
By Application, Orthopaedic surgery was the highest revenue-grossing segment in the global general surgical devices market in 2022 owing to increasing prevalence of bone diseases, rising geriatric population growing favourable reimbursement, surge in demand for diagnosis methods & imaging technology in orthopaedic surgery, and increasing launch of new products. For instance, in November 2021, OrthAlign, Inc., has officially launched Lantern, the newest smart surgical technology designed for total and partial knee replacement surgery. Additionally, Cardiology is predicted to grow at fastest CAGR during the forecast period owing to rising lifestyle changes, growing prevalence of cardiovascular disorders, and increasing technological developments.
By End-user, Hospitals was the highest revenue-grossing segment in the global general surgical devices market in 2022 owing to increasing healthcare expenditure, surge in number of hospitals, rising technological advancements, and growing introduction of innovative products. Additionally, Ambulatory surgical centers is predicted to grow at fastest CAGR during the forecast period owing to the increasing public awareness for one-day procedures, rising usage of cutting-edge surgical equipment, growing reimbursement policies, and surge in approval for innovative products by regulatory bodies. For instance, in June 2022, Xenco Medical has broadened its portfolio of surgical devices for ambulatory surgical centers (ASCs) with the clearance and release of the Multilevel CerviKit by the United States Food and Drug Administration. This new addition builds upon Xenco Medical's pioneering single-use cervical spine technology, now offering a complete range of implants and single-use instruments suitable for anterior cervical spine procedures involving 2, 3, and 4 levels.
North America region is anticipated for the highest revenue share during the forecast period owing to the rising favourable reimbursement policies, increasing healthcare expenditures, growing demand for innovative products, and surge in launch of new products. For instance, in September 2021, Ethicon, a division of Johnson & Johnson Medical Devices Companies, introduced ECHELON ENDOPATH Staple Line Reinforcement (SLR), an innovative buttressing device aimed at enhancing staple line durability and minimizing potential complications in bariatric, thoracic, and general surgical procedures. Additionally, Asia Pacific region is predicted to grow at fastest CAGR during the forecast period owing to the increasing investment by major market players, rising government initiatives for improvements in reimbursement policies, surge in awareness about reconstructive or plastic surgeries, growing technological advancements, and increasing introduction of technologically advanced systems. For instance, in July 2022, SS Innovations, headquartered in New Delhi, unveiled SSI Mantra, India's inaugural general robotic surgery system, and the Rajiv Gandhi Cancer Institute became its first commercial installation.
Segmentation: General Surgical Devices Market Report 2022 - 2033
General Surgical Devices Market Analysis & Forecast by Type 2022 - 2033 (Revenue USD Bn)
- Open Surgery Instrument
- Disposable Surgical Supplies
- Adhesion Prevention Products
- Minimally Invasive Surgery Instruments
- Energy-based & Powered Instrument
- Medical Robotics & Computer Assisted Surgery Devices
General Surgical Devices Market Analysis & Forecast by Product 2022 - 2033 (Revenue USD Bn)
- Electro Surgical Devices
- Handheld Devices
- Wound Closure Devices
- Laparoscopic Devices
- Trocars and Access Devices
- Other
General Surgical Devices Market Analysis & Forecast by Application 2022 - 2033 (Revenue USD Bn)
- Plastic Surgery
- Neurosurgery
- Orthopaedic Surgery
- Audiology
- Cardiology
- Ophthalmology
- Wound Care
- Urology and Gynaecology Surgery
- Thoracic Surgery
- Others
General Surgical Devices Market Analysis & Forecast by End-user 2022 - 2033 (Revenue USD Bn)
- Ambulatory Surgical Centers
- Hospitals
- Specialty Clinics
General Surgical Devices Market Analysis & Forecast by Region 2022 - 2033 (Revenue USD Bn)
North America
- U.S.
- Canada
Europe
- Germany
- France
- UK
- Spain
- Italy
- Rest of Europe
Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of APAC
Latin America
- Brazil
- Mexico
- Argentina
- Rest of LATAM
Middle East & Africa
- South Africa
- GCC
- Rest of MEA
Table of Contents
1. Research Methodology
2. Introduction
4. Market Environment Analysis
5. Market Dynamics
7. General Surgical Devices Market: Type Estimates & Trend Analysis
8. General Surgical Devices Market: Product Estimates & Trend Analysis
9. General Surgical Devices Market: Application Estimates & Trend Analysis
10. General Surgical Devices Market: End-user Estimates & Trend Analysis
11. Regional Market Analysis
12. North America General Surgical Devices Market
13. Europe Global General Surgical Devices Market
14. Asia Pacific Global General Surgical Devices Market
15. Latin America Global General Surgical Devices Market
16. MEA Global General Surgical Devices Market
17. Competitor Analysis
18. Company Profiles
Companies Mentioned
- Medtronic Plc
- Olympus Corporation
- Johnson & Johnson Service Inc.
- Smith & Nephew
- Cadence Inc
- Conmed Corporation
- Becton
- Dickinson and Company (BD)
- Erbe Elektromedizin Gmbh
- Integer Holdings Corporation
- Integra LifeSciences
- Stryker
- 3M Healthcare
- B. Braun Melsungen Ag
- Boston Scientific Corporation
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 145 |
| Published | August 2023 |
| Forecast Period | 2022 - 2033 |
| Estimated Market Value ( USD | $ 16.38 Billion |
| Forecasted Market Value ( USD | $ 43.3 Billion |
| Compound Annual Growth Rate | 9.2% |
| Regions Covered | Global |
| No. of Companies Mentioned | 15 |
